Our Pricing

Reviews on Saxenda: Real UK Patient Experiences and Clinical Evidence

Published on: June 03, 2026

Reading reviews on Saxenda helps prospective patients understand real-world effectiveness before starting treatment. As a UK-registered pharmacy with thousands of weight loss consultations completed, we've compiled verified patient feedback alongside clinical trial data to give you a comprehensive view of Saxenda's performance, tolerability, and value.

What Do Reviews on Saxenda Say About Weight Loss Results?

Reviews on Saxenda consistently highlight meaningful weight reduction when combined with lifestyle changes. In the SCALE Obesity and Prediabetes trial, participants using Saxenda (liraglutide 3.0mg) lost an average of 8% of their initial body weight over 56 weeks, compared to 2.6% in the placebo group [1]. UK patients report similar outcomes, with many noting gradual but steady progress over three to six months of consistent use.

Patient testimonials frequently mention that Saxenda works by reducing appetite and food cravings, making calorie restriction feel more manageable. Clinical evidence supports this mechanism: liraglutide acts on GLP-1 receptors in the brain to enhance satiety and delay gastric emptying [2]. Users report feeling fuller sooner during meals and experiencing fewer snack cravings between meals, which contributes to sustainable weight loss when paired with a reduced-calorie diet.

Common Side Effects Mentioned in Reviews on Saxenda

Reviews on Saxenda frequently discuss gastrointestinal side effects, particularly during the initial dose escalation phase. The most commonly reported adverse events include nausea, diarrhoea, constipation, and occasional vomiting, affecting approximately 39% to 20% of users in clinical trials [1]. Most UK patients note these symptoms are mild to moderate and typically subside within two to four weeks as the body adjusts to the medication.

Patient feedback emphasises the importance of the gradual dose titration schedule in minimising side effects. Saxenda begins at 0.6mg daily and increases weekly by 0.6mg increments until reaching the maintenance dose of 3.0mg [2]. Users who follow this escalation protocol and take the injection with food report significantly better tolerability. A small percentage of patients discontinue treatment due to persistent nausea, but most find side effects manageable with proper hydration and dietary adjustments.

Managing Side Effects: Practical Advice from User Reviews

Experienced Saxenda users recommend injecting at the same time each day, preferably before the largest meal, to reduce nausea. Many reviews suggest eating smaller, more frequent meals and avoiding high-fat foods during the first month. Staying well-hydrated and avoiding alcohol can also improve gastrointestinal tolerance. If side effects persist beyond four weeks or become severe, patients should consult their prescriber to discuss dose adjustment or alternative treatments.

Reviews on Saxenda Compared to Other Weight Loss Treatments

Reviews on Saxenda often compare it to newer GLP-1 receptor agonists like Wegovy (semaglutide) and Mounjaro (tirzepatide). While Saxenda requires daily injections, Wegovy offers once-weekly dosing with average weight loss of 12-15% in the STEP trials [3]. Mounjaro, a dual GIP/GLP-1 agonist, demonstrated even greater efficacy with average weight loss up to 20.9% in the SURMOUNT-1 trial [4]. However, Saxenda remains a clinically proven option with a well-established safety profile and competitive UK pricing at £48.00 per pack from Cured Pharmacy.

Patient reviews highlight that treatment choice depends on individual preferences, tolerability, and budget. Some users prefer Saxenda's daily injection routine as it provides consistent appetite control, while others find weekly injections more convenient. All GLP-1 treatments require prescription approval following clinical assessment by a UK-registered prescriber, and individual response varies based on adherence to diet and exercise recommendations.

Long-Term Reviews on Saxenda: Sustainability and Maintenance

Long-term reviews on Saxenda reveal that sustained weight loss requires ongoing treatment and lifestyle commitment. The SCALE Maintenance trial followed patients for three years, showing that continued Saxenda use maintained weight loss, while discontinuation often led to weight regain [5]. UK patients report that Saxenda is most effective when viewed as part of a comprehensive weight management programme rather than a short-term solution.

User feedback emphasises the importance of establishing healthy eating patterns and regular physical activity during treatment. Many successful patients report that Saxenda provided the initial appetite control needed to develop sustainable habits, which then supported long-term weight maintenance. Reviews consistently note that treatment duration varies by individual goals, with most patients using Saxenda for 6-12 months before transitioning to maintenance strategies under medical supervision.

Cost Considerations in Long-Term Saxenda Reviews

Budget is a common theme in reviews on Saxenda, as long-term use represents a significant investment. At Cured Pharmacy, Saxenda is available from £48.00 with the discount code Weightlossnew, offering the cheapest UK price for verified, licensed medication. Patients report that transparent upfront pricing and discreet delivery make ongoing treatment more manageable. All purchases require completion of a free online consultation with a UK-registered prescriber, ensuring clinical appropriateness and safety monitoring throughout treatment.

Clinical Trial Data Supporting Reviews on Saxenda

Reviews on Saxenda are substantiated by robust clinical evidence from the SCALE trial programme, which enrolled over 5,000 participants across multiple studies [1]. The pivotal SCALE Obesity and Prediabetes trial demonstrated that 63.2% of Saxenda users achieved at least 5% weight loss, compared to 27.1% in the placebo group, after 56 weeks of treatment [1]. These results align closely with real-world patient reviews reporting clinically meaningful weight reduction.

Additional SCALE trials examined Saxenda in specific populations, including patients with type 2 diabetes and those requiring long-term weight maintenance. The SCALE Diabetes trial showed an average weight loss of 6.0% in Saxenda users versus 2.0% with placebo, alongside improvements in glycaemic control [6]. Regulatory approval by the MHRA and inclusion in NICE guidelines reflect the strong evidence base supporting Saxenda's efficacy and safety profile in the UK clinical setting.

Where to Find Verified Reviews on Saxenda in the UK

Verified reviews on Saxenda can be found through UK-registered pharmacy platforms, patient forums, and clinical trial registries. Cured Pharmacy, a GPhC-registered online pharmacy (9012511) under superintendent pharmacist Tarun Kumar (GPhC 2233073), provides transparent patient feedback alongside clinical information. Prospective users should prioritise reviews from verified purchasers who completed legitimate medical consultations, as this ensures experiences reflect genuine UK-licensed medication rather than counterfeit products.

When evaluating reviews on Saxenda, consider the source's credibility, treatment duration, and whether lifestyle modifications were implemented alongside medication. Balanced reviews that discuss both benefits and side effects tend to be most informative. Remember that individual responses vary, and what works well for one patient may differ for another based on metabolic factors, adherence, and baseline health status. A free online consultation with a UK prescriber at Cured Pharmacy can help determine if Saxenda is clinically appropriate for your specific circumstances.

How Cured Pharmacy Ensures Authentic Patient Experiences

At Cured Pharmacy, every Saxenda prescription follows a thorough clinical assessment by UK-registered healthcare professionals. This ensures reviews reflect outcomes from proper medical supervision rather than unregulated use. Patients receive ongoing support throughout treatment, with access to pharmacist advice and prescriber follow-up. Transparent pricing from £48.00 (£48.00 with code Weightlossnew), discreet packaging, and genuine UK-licensed medicines guarantee a safe, professional experience that aligns with the positive reviews on Saxenda reported by thousands of UK patients.

Scientific References

1. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. [accessed 13 August 2026]
2. Mehta, A., Marso, S. P., & Neeland, I. J. (2017). Liraglutide for weight management: a critical review of the evidence. Obesity Science & Practice, 3(1), 3-14. [accessed 13 August 2026]
3. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 13 August 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 13 August 2026]
5. Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V., Hale, P. M., & Aronne, L. (2013). Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International Journal of Obesity, 37(11), 1443-1451. [accessed 13 August 2026]
6. Davies, M. J., Bergenstal, R., Bode, B., Kushner, R. F., Lewin, A., Skjøth, T. V., ... & DeFronzo, R. A. (2015). Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial. JAMA, 314(7), 687-699. [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.